Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
Neurology. 2021 Mar 23;96(12):e1595-e1607. doi: 10.1212/WNL.0000000000011626. Epub 2021 Feb 17.
Neurology. 2021.
PMID: 33597289
Free PMC article.
Clinical Trial.
OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). ...CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with sIBM, long-term treatment with bimagrumab was saf …
OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). ...CLASS …
Interventions for dysphagia in long-term, progressive muscle disease.
Jones K, Pitceathly RD, Rose MR, McGowan S, Hill M, Badrising UA, Hughes T.
Jones K, et al. Among authors: badrising ua.
Cochrane Database Syst Rev. 2016 Feb 9;2(2):CD004303. doi: 10.1002/14651858.CD004303.pub4.
Cochrane Database Syst Rev. 2016.
PMID: 26859621
Free PMC article.
Review.
From our search for RCTs, we identified two other non-randomised studies, which reported the effects of long-term intravenous immunoglobulin therapy in adults with IBM and lip-strengthening exercises in children with myotonic dystrophy type 1. Headaches affected two partic …
From our search for RCTs, we identified two other non-randomised studies, which reported the effects of long-term intravenous immunog …
Item in Clipboard
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.
Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA.
Cox FM, et al. Among authors: badrising ua.
Brain. 2011 Nov;134(Pt 11):3167-75. doi: 10.1093/brain/awr217. Epub 2011 Sep 9.
Brain. 2011.
PMID: 21908393
Sporadic inclusion body myositis is considered to be a slowly progressive myopathy. Long-term follow-up data are, however, not yet available. Follow-up data are important with a view to informing patients about their prognosis and selecting appropriate outcome measures for …
Sporadic inclusion body myositis is considered to be a slowly progressive myopathy. Long-term follow-up data are, however, not yet av …
Item in Clipboard
Pain in Guillain-Barre syndrome: a long-term follow-up study.
Ruts L, Drenthen J, Jongen JL, Hop WC, Visser GH, Jacobs BC, van Doorn PA; Dutch GBS Study Group.
Ruts L, et al.
Neurology. 2010 Oct 19;75(16):1439-47. doi: 10.1212/WNL.0b013e3181f88345. Epub 2010 Sep 22.
Neurology. 2010.
PMID: 20861454
Item in Clipboard
Cite
Cite